Literature DB >> 4533223

A rapid method for the differentiation of Haemophilus strains. The porphyrin test;.

M Kilian.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4533223     DOI: 10.1111/j.1699-0463.1974.tb02381.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol        ISSN: 0365-5571


× No keyword cloud information.
  55 in total

1.  In vitro activity of clarithromycin and its 14-hydroxy-metabolite against 203 strains of Haemophilus influenzae.

Authors:  M G Bergeron; M Bernier; J L'Ecuyer
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

2.  Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.

Authors:  L D Tremblay; J L'Ecuyer; P Provencher; M G Bergeron
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

3.  Identification of Haemophilus influenzae.

Authors:  M Powell
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

4.  Clinical and microbiologic characteristics of pediococci.

Authors:  W J Riebel; J A Washington
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

5.  Differentiation of Haemophilus spp. in Respiratory isolate cultures by an indole spot test.

Authors:  D F Welch; P A Ahlin; J M Matsen
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

6.  Biotypes of Haemophilus encountered in clinical laboratories.

Authors:  T R Oberhofer; A E Back
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948

7.  Biochemical characteristics of 130 recent isolates from Haemophilus influenzae meningitis.

Authors:  M Kilian; I Sørensen; W Frederiksen
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

8.  Increased frequency of isolation of Pasteurella and Actinobacillus species and related organisms.

Authors:  R Sakazaki; E Yoshizaki; K Tamura; S Kuramochi
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

9.  Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.

Authors:  Michael E Pichichero; Gary V Doern; Joseph L Kuti; David P Nicolau
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Simple screening method for beta-lactamase-positive and -negative ampicillin-resistant Haemophilus influenzae isolates.

Authors:  T R Parr; C H Pai; L E Bryan
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.